{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:52:38Z","timestamp":1767153158165,"version":"build-2238731810"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["18K17387"],"award-info":[{"award-number":["18K17387"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We investigated the potential of mid-regional pro-adrenomedullin (MR-proADM) for use as a novel biomarker for arterial stiffness as the criterion for vascular failure and cardiometabolic disease (obesity, hypertension, dyslipidemia, diabetes, and metabolic syndrome) compared with high-sensitivity C-reactive protein (hsCRP). Overall, 2169 individuals (702 men and 1467 women) were enrolled. Multiple regression analysis was performed to assess the association of MR-proADM and hsCRP with brachial-ankle pulse wave velocity (baPWV), adjusting for other variables. The diagnostic performance (accuracy) of MR-proADM with regard to the index of vascular failure was tested with the help of receiver operating characteristic curve analysis in the models. MR-proADM was significantly higher in participants with vascular failure, as defined by baPWV and\/or its risk factors (obesity, hypertension, dyslipidemia, diabetes, and metabolic syndrome), than in control groups. Independent of cardiovascular risk factors (age, drinking, smoking, body mass index, systolic blood pressure, lipid and glycol metabolism), MR-proADM was significantly associated with baPWV, and MR-proADM showed higher areas under the curve of baPWV than hsCRP showed. MR-proADM is more suitable for the diagnosis of higher arterial stiffness as the criterion for vascular failure than hsCRP. Because vascular assessment is important to mitigate the most significant modifiable cardiovascular risk factors, MR-proADM may be useful as a novel biomarker on routine blood examination.<\/jats:p>","DOI":"10.1038\/s41598-020-79525-2","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T06:25:44Z","timestamp":1610346344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Mid-regional pro-adrenomedullin is a novel biomarker for arterial stiffness as the criterion for vascular failure in a cross-sectional study"],"prefix":"10.1038","volume":"11","author":[{"given":"Teruhide","family":"Koyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagato","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoshi","family":"Iwao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takakuni","family":"Maki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritei","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"79525_CR1","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1097\/01.hjh.0000249684.76296.4f","volume":"24","author":"T Inoue","year":"2006","unstructured":"Inoue, T. & Node, K. Vascular failure: A new clinical entity for vascular disease. J. Hypertens. 24, 2121\u20132130 (2006).","journal-title":"J. Hypertens."},{"key":"79525_CR2","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.118.11554","volume":"72","author":"A Tanaka","year":"2018","unstructured":"Tanaka, A. et al. Physiological diagnostic criteria for vascular failure. Hypertension 72, 1060\u20131071 (2018).","journal-title":"Hypertension"},{"key":"79525_CR3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1006\/bbrc.1993.1451","volume":"192","author":"K Kitamura","year":"1993","unstructured":"Kitamura, K. et al. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192, 553\u2013560 (1993).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"79525_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.5551\/jat.29967","volume":"22","author":"T Koyama","year":"2015","unstructured":"Koyama, T. et al. Adrenomedullin-RAMP2 system in vascular endothelial cells. J. Atheroscler. Thromb. 22, 647\u2013653 (2015).","journal-title":"J. Atheroscler. Thromb."},{"key":"79525_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/187221412799015263","volume":"6","author":"BM Cheung","year":"2012","unstructured":"Cheung, B. M. & Tang, F. Adrenomedullin: Exciting new horizons. . Recent Pat. Endocr. Metab. Immune Drug Discov. 6, 4\u201317 (2012).","journal-title":"Recent Pat. Endocr. Metab. Immune Drug Discov."},{"key":"79525_CR6","doi-asserted-by":"publisher","first-page":"R1019","DOI":"10.1152\/ajpregu.2000.278.4.R1019","volume":"278","author":"N Nagaya","year":"2000","unstructured":"Nagaya, N. et al. Cardiac adrenomedullin gene expression and peptide accumulation after acute myocardial infarction in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278, R1019-1026 (2000).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"79525_CR7","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1152\/physrev.00037.2003","volume":"84","author":"SD Brain","year":"2004","unstructured":"Brain, S. D. & Grant, A. D. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol. Rev. 84, 903\u2013934 (2004).","journal-title":"Physiol. Rev."},{"key":"79525_CR8","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1172\/JCI117573","volume":"94","author":"T Ishimitsu","year":"1994","unstructured":"Ishimitsu, T. et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J. Clin. Investig. 94, 2158\u20132161 (1994).","journal-title":"J. Clin. Investig."},{"key":"79525_CR9","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0140-6736(05)64211-0","volume":"350","author":"M Hayashi","year":"1997","unstructured":"Hayashi, M. et al. Plasma adrenomedullin in diabetes. Lancet 350, 1449\u20131450 (1997).","journal-title":"Lancet"},{"key":"79525_CR10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1213\/00000539-199810000-00021","volume":"87","author":"K Kikumoto","year":"1998","unstructured":"Kikumoto, K. et al. Increased plasma concentration of adrenomedullin in patients with subarachnoid hemorrhage. Anesth. Analg. 87, 859\u2013863 (1998).","journal-title":"Anesth. Analg."},{"key":"79525_CR11","first-page":"1449","volume":"81","author":"Y Hirata","year":"1996","unstructured":"Hirata, Y. et al. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J. Clin. Endocrinol. Metab. 81, 1449\u20131453 (1996).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"79525_CR12","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1161\/CIRCULATIONAHA.106.652842","volume":"115","author":"D Levy","year":"2007","unstructured":"Levy, D. et al. Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: The Framingham heart study. Circulation 115, 3079\u20133085 (2007).","journal-title":"Circulation"},{"key":"79525_CR13","first-page":"95","volume":"82","author":"K Meeran","year":"1997","unstructured":"Meeran, K. et al. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: A pharmacokinetic study. J. Clin. Endocrinol. Metab. 82, 95\u2013100 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"79525_CR14","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.clinbiochem.2009.01.002","volume":"42","author":"P Caruhel","year":"2009","unstructured":"Caruhel, P., Mazier, C., Kunde, J., Morgenthaler, N. G. & Darbouret, B. Homogeneous time-resolved fluoroimmunoassay for the measurement of midregional proadrenomedullin in plasma on the fully automated system B.R.A.H.M.S KRYPTOR. Clin. Biochem. 42, 725\u2013728 (2009).","journal-title":"Clin. Biochem."},{"key":"79525_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1373\/clinchem.2017.275172","volume":"64","author":"K Aleksandrova","year":"2018","unstructured":"Aleksandrova, K., Mozaffarian, D. & Pischon, T. Addressing the perfect storm: Biomarkers in obesity and pathophysiology of cardiometabolic risk. Clin. Chem. 64, 142\u2013153 (2018).","journal-title":"Clin. Chem."},{"key":"79525_CR16","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.2337\/dc06-1899","volume":"30","author":"SC Lim","year":"2007","unstructured":"Lim, S. C. et al. The relationship between adrenomedullin, metabolic factors, and vascular function in individuals with type 2 diabetes. Diabetes Care 30, 1513\u20131519 (2007).","journal-title":"Diabetes Care"},{"key":"79525_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.atherosclerosis.2013.03.006","volume":"228","author":"JT Neumann","year":"2013","unstructured":"Neumann, J. T. et al. Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease. Atherosclerosis 228, 451\u2013459 (2013).","journal-title":"Atherosclerosis"},{"key":"79525_CR18","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/HJH.0000000000001893","volume":"37","author":"T Ohlsson","year":"2019","unstructured":"Ohlsson, T., Nilsson, P. M., Persson, M. & Melander, O. Midregional proadrenomedullin predicts reduced blood pressure and glucose elevation over time despite enhanced progression of obesity markers. J. Hypertens. 37, 590\u2013595 (2019).","journal-title":"J. Hypertens."},{"key":"79525_CR19","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1515\/cclm-2017-1044","volume":"56","author":"M Krintus","year":"2018","unstructured":"Krintus, M. et al. Plasma midregional proadrenomedullin (MR-proADM) concentrations and their biological determinants in a reference population. Clin. Chem. Lab. Med. 56, 1161\u20131168 (2018).","journal-title":"Clin. Chem. Lab. Med."},{"key":"79525_CR20","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1530\/EJE-12-0472","volume":"167","author":"J Seissler","year":"2012","unstructured":"Seissler, J. et al. Vasoregulatory peptides pro-endothelin-1 and pro-adrenomedullin are associated with metabolic syndrome in the population-based KORA F4 study. Eur. J. Endocrinol. 167, 847\u2013853 (2012).","journal-title":"Eur. J. Endocrinol."},{"key":"79525_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0006-291X(03)00903-3","volume":"306","author":"M Abe","year":"2003","unstructured":"Abe, M. et al. Adrenomedullin augments collateral development in response to acute ischemia. Biochem. Biophys. Res. Commun. 306, 10\u201315 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"79525_CR22","doi-asserted-by":"publisher","first-page":"H1506","DOI":"10.1152\/ajpheart.00270.2003","volume":"285","author":"K Kato","year":"2003","unstructured":"Kato, K. et al. Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. Am. J. Physiol. Heart Circ. Physiol. 285, H1506\u2013H1514 (2003).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"79525_CR23","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1161\/01.CIR.0000117231.40057.6D","volume":"109","author":"J Kawai","year":"2004","unstructured":"Kawai, J. et al. Endogenous adrenomedullin protects against vascular response to injury in mice. Circulation 109, 1147\u20131153 (2004).","journal-title":"Circulation"},{"key":"79525_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0014-5793(99)01615-4","volume":"463","author":"Y Isumi","year":"1999","unstructured":"Isumi, Y., Kubo, A., Katafuchi, T., Kangawa, K. & Minamino, N. Adrenomedullin suppresses interleukin-1beta-induced tumor necrosis factor-alpha production in Swiss 3T3 cells. FEBS Lett. 463, 110\u2013114 (1999).","journal-title":"FEBS Lett."},{"key":"79525_CR25","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1161\/CIRCULATIONAHA.112.000756","volume":"127","author":"T Koyama","year":"2013","unstructured":"Koyama, T. et al. Vascular endothelial adrenomedullin-RAMP2 system is essential for vascular integrity and organ homeostasis. Circulation 127, 842\u2013853 (2013).","journal-title":"Circulation"},{"key":"79525_CR26","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1210\/en.2016-1531","volume":"158","author":"X Xian","year":"2017","unstructured":"Xian, X. et al. Vasoprotective activities of the adrenomedullin-RAMP2 system in endothelial cells. Endocrinology 158, 1359 (2017).","journal-title":"Endocrinology"},{"key":"79525_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1172\/JCI33022","volume":"118","author":"Y Ichikawa-Shindo","year":"2008","unstructured":"Ichikawa-Shindo, Y. et al. The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity. J. Clin. Investig. 118, 29\u201339 (2008).","journal-title":"J. Clin. Investig."},{"key":"79525_CR28","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1097\/HJH.0b013e328362fe99","volume":"31","author":"M Gottsater","year":"2013","unstructured":"Gottsater, M. et al. Adrenomedullin is a marker of carotid plaques and intima-media thickness as well as brachial pulse pressure. J. Hypertens. 31, 1959\u20131965 (2013).","journal-title":"J. Hypertens."},{"key":"79525_CR29","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1291\/hypres.26.887","volume":"26","author":"T Kita","year":"2003","unstructured":"Kita, T., Kitamura, K., Hashida, S., Morishita, K. & Eto, T. Plasma adrenomedullin is closely correlated with pulse wave velocity in middle-aged and elderly patients. Hypertens. Res. 26, 887\u2013893 (2003).","journal-title":"Hypertens. Res."},{"key":"79525_CR30","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.5551\/jat.41517","volume":"24","author":"T Koyama","year":"2017","unstructured":"Koyama, T. et al. Genetic variants of RAMP2 and CLR are associated with stroke. J. Atheroscler. Thromb. 24, 1267\u20131281 (2017).","journal-title":"J. Atheroscler. Thromb."},{"key":"79525_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1373\/clinchem.2010.157842","volume":"58","author":"PS Wild","year":"2012","unstructured":"Wild, P. S. et al. Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: Results from the AtheroGene study. Clin. Chem. 58, 226\u2013236 (2012).","journal-title":"Clin. Chem."},{"key":"79525_CR32","first-page":"1433","volume":"52","author":"WF Peacock","year":"2014","unstructured":"Peacock, W. F. Novel biomarkers in acute heart failure: MR-pro-adrenomedullin. Clin. Chem. Lab. Med. 52, 1433\u20131435 (2014).","journal-title":"Clin. Chem. Lab. Med."},{"key":"79525_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.medin.2018.04.005","volume":"43","author":"JL Perez-Navero","year":"2019","unstructured":"Perez-Navero, J. L. et al. Evaluation of the vasoactive-inotropic score, mid-regional pro-adrenomedullin and cardiac troponin I as predictors of low cardiac output syndrome in children after congenital heart disease surgery. Med. Intens. 43, 329\u2013336 (2019).","journal-title":"Med. Intens."},{"key":"79525_CR34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1161\/HYPERTENSIONAHA.112.191874","volume":"60","author":"RB Schnabel","year":"2012","unstructured":"Schnabel, R. B. et al. Multiple endothelial biomarkers and noninvasive vascular function in the general population: The Gutenberg health study. Hypertension 60, 288\u2013295 (2012).","journal-title":"Hypertension"},{"key":"79525_CR35","doi-asserted-by":"publisher","first-page":"113168","DOI":"10.1016\/j.jpba.2020.113168","volume":"183","author":"M Iwao","year":"2020","unstructured":"Iwao, M. et al. Sensitive and selective quantification of mid-regional proadrenomedullin in human plasma using ultra-performance liquid chromatography coupled with tandem mass spectrometry. J. Pharm. Biomed. Anal. 183, 113168 (2020).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"79525_CR36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2188\/jea.JE20100139","volume":"21","author":"K Wakai","year":"2011","unstructured":"Wakai, K. et al. Profile of participants and genotype distributions of 108 polymorphisms in a cross-sectional study of associations of genotypes with lifestyle and clinical factors: A project in the Japan multi-institutional collaborative cohort (J-MICC) study. J. Epidemiol. 21, 223\u2013235 (2011).","journal-title":"J. Epidemiol."},{"key":"79525_CR37","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20200147","author":"K Takeuchi","year":"2020","unstructured":"Takeuchi, K. et al. Study profile of the Japan multi-institutional collaborative cohort (J-MICC) study. J. Epidemiol. https:\/\/doi.org\/10.2188\/jea.JE20200147 (2020).","journal-title":"J. Epidemiol."},{"key":"79525_CR38","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.3390\/ijerph17113968","volume":"17","author":"T Koyama","year":"2020","unstructured":"Koyama, T., Kuriyama, N. & Uehara, R. Midregional proadrenomedullin can reflect the accumulation of visceral adipose tissue\u2014A key to explaining the obesity paradox. Int. J. Environ. Res. Public Health 17, 3968 (2020).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"79525_CR39","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1253\/circj.66.987","volume":"66","author":"Examination Committee of Criteria for 'Obesity Disease' in Japan","year":"2002","unstructured":"Examination Committee of Criteria for \u201cObesity Disease\u201d in Japan & Japan Society for the Study of Obesity. New criteria for \u201cobesity disease\u201d in Japan. Circ. J. 66, 987\u2013992 (2002).","journal-title":"Circ. J."},{"key":"79525_CR40","doi-asserted-by":"publisher","first-page":"e2017003","DOI":"10.4178\/epih.e2017003","volume":"39","author":"K Yamagishi","year":"2017","unstructured":"Yamagishi, K. & Iso, H. The criteria for metabolic syndrome and the national health screening and education system in Japan. Epidemiol. Health 39, e2017003 (2017).","journal-title":"Epidemiol. Health"}],"updated-by":[{"DOI":"10.1038\/s41598-021-96984-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79525-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79525-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79525-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T20:19:46Z","timestamp":1670012386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79525-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["79525"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-79525-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"7 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-021-96984-3","URL":"https:\/\/doi.org\/10.1038\/s41598-021-96984-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"305"}}